Weight-Loss GLP-1s Under Scrutiny: Spotting Fake Compounded Semaglutide, Tirzepatide vs. What Real Pharmacies Should Do
The explosion of interest in GLP-1 receptor agonists, most notably semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), has transformed the landscape of obesity treatment. These once-weekly injections, originally developed for diabetes, are now among the most in-demand weight-loss drugs in the United States. Their proven ability to promote sustained weight reduction and improve metabolic health […]